Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-01-07

Clinical Trial Update: Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

View source ↗

Summary

Clinical trial update describing a study at Xiangya Hospital evaluating urinary proteomic biomarkers to distinguish ovarian malignancy and track disease progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Ovarian Cancer (OvCa) | Status: RECRUITING